ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

The 21st Century Cures Act

by Karen Appold • August 15, 2017

  • Tweet
  • Email
Print-Friendly Version

Dr. Sinha, along with other members of the PORTAL Research Group, noted in Health Affairs Blog and JAMA that they are concerned about the impact of the Cures Act on patients (JAMA. 2017;317:581-582). “Allowing drug approvals on the basis of less rigorous data—such as through the limited population pathway for antibiotics—will lead to numerous products becoming available without clear evidence of benefit to guide physician and patient decision-making,” he said. For example, it will be increasingly difficult for physicians to base their confidence in a drug’s safety and efficacy on FDA approval alone, particularly as biomarkers and other surrogate measures replace meaningful clinical endpoints in pivotal studies leading to approval. “Of course, all of these products will invariably be extremely expensive as well, which will put a strain on limited healthcare budgets and possibly detract from already available, well-proven therapies.”

You Might Also Like

No related posts.

Explore This Issue
August 2017

Pages: 1 2 3 4 | Single Page

Filed Under: Departments, Health Policy Tagged With: 21st century cures act, biomedical research, national institutes of health, NIH, otolaryngologyIssue: August 2017

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • What Happens to Medical Students Who Don’t Match?
    • Complications for When Physicians Change a Maiden Name
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • What Happens to Medical Students Who Don’t Match?
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Vertigo in the Elderly: What Does It Mean?
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • Why We Get Colds
    • Are the Jobs in Healthcare Good Jobs?
    • What Really Works in Functional Rhinoplasty?
    • Is the Best Modality to Assess Vocal Fold Mobility in Children Flexible Fiberoptic Laryngoscopy or Ultrasound?
    • Three Primary Treatment Strategies Show No Differences in Swallow Outcome for Patients with Low- to Intermediate-Risk Tonsil Cancer

Polls

Do you have physician assistants in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2023 The Triological Society. All Rights Reserved.
ISSN 1559-4939